Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DARATUMUMAB Cause Sars-cov-2 test positive? 28 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Sars-cov-2 test positive have been filed in association with DARATUMUMAB (DARZALEX). This represents 0.1% of all adverse event reports for DARATUMUMAB.

28
Reports of Sars-cov-2 test positive with DARATUMUMAB
0.1%
of all DARATUMUMAB reports
4
Deaths
21
Hospitalizations

How Dangerous Is Sars-cov-2 test positive From DARATUMUMAB?

Of the 28 reports, 4 (14.3%) resulted in death, 21 (75.0%) required hospitalization, and 3 (10.7%) were considered life-threatening.

Is Sars-cov-2 test positive Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DARATUMUMAB. However, 28 reports have been filed with the FAERS database.

What Other Side Effects Does DARATUMUMAB Cause?

Plasma cell myeloma (2,980) Infusion related reaction (2,557) Off label use (2,494) Pneumonia (1,450) Neutropenia (1,351) Drug ineffective (1,110) Thrombocytopenia (1,089) Death (1,088) Pyrexia (1,032) Dyspnoea (996)

What Other Drugs Cause Sars-cov-2 test positive?

OCRELIZUMAB (1,421) ADALIMUMAB (1,301) DUPILUMAB (860) NIRMATRELVIR\RITONAVIR (538) LENALIDOMIDE (469) SECUKINUMAB (378) CERTOLIZUMAB PEGOL (361) RISANKIZUMAB-RZAA (335) RITUXIMAB (305) UPADACITINIB (281)

Which DARATUMUMAB Alternatives Have Lower Sars-cov-2 test positive Risk?

DARATUMUMAB vs DARATUMUMAB\HYALURONIDASE-FIHJ DARATUMUMAB vs DARBEPOETIN ALFA DARATUMUMAB vs DARIDOREXANT DARATUMUMAB vs DARIFENACIN HYDROBROMIDE DARATUMUMAB vs DAROLUTAMIDE

Related Pages

DARATUMUMAB Full Profile All Sars-cov-2 test positive Reports All Drugs Causing Sars-cov-2 test positive DARATUMUMAB Demographics